{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:39:21Z","timestamp":1793299161294,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00464-026-12749-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:39:27Z","timestamp":1774287567000},"page":"5207-5219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinguishing second primary tumors from local recurrence in type 1 gastric neuroendocrine tumors: a risk-stratified management strategy"],"prefix":"10.1007","volume":"40","author":[{"given":"Jing","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-1831","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"12749_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182\u2013188. https:\/\/doi.org\/10.1111\/his.13975","journal-title":"Histopathology"},{"key":"12749_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp-2023-209060","volume":"78","author":"CC Juhlin","year":"2024","unstructured":"Juhlin CC (2024) The road ahead: a brief guide to navigating the 2022 WHO classification of endocrine and neuroendocrine tumours. J Clin Pathol 78:1\u201310. https:\/\/doi.org\/10.1136\/jcp-2023-209060","journal-title":"J Clin Pathol"},{"key":"12749_CR3","unstructured":"WHO Classification of Tumours Editorial Board (ed) (2019) Digestive system tumours: WHO classification of tumours, 5th edition. IARC Publications"},{"key":"12749_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.dld.2023.12.015","volume":"56","author":"F Panzuto","year":"2024","unstructured":"Panzuto F et al (2024) Endoscopic management of gastric, duodenal and rectal NETs: position paper from the Italian association for neuroendocrine tumors (Itanet), Italian society of gastroenterology (SIGE), Italian society of digestive endoscopy (SIED). Dig Liver Dis 56:589\u2013600. https:\/\/doi.org\/10.1016\/j.dld.2023.12.015","journal-title":"Dig Liver Dis"},{"key":"12749_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13306","author":"F Panzuto","year":"2023","unstructured":"Panzuto F et al (2023) European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1\u2013G3. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.13306","journal-title":"J Neuroendocrinol"},{"key":"12749_CR6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.4158\/ep-2017-0056","volume":"23","author":"JW Hughes","year":"2017","unstructured":"Hughes JW et al (2017) High-risk gastric pathology and prevalent autoimmune diseases in patients with pernicious anemia. Endocr Pract 23:1297\u20131303. https:\/\/doi.org\/10.4158\/ep-2017-0056","journal-title":"Endocr Pract"},{"key":"12749_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s40618-016-0445-5","volume":"39","author":"C Castoro","year":"2016","unstructured":"Castoro C et al (2016) Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. J Endocrinol Invest 39:779\u2013784. https:\/\/doi.org\/10.1007\/s40618-016-0445-5","journal-title":"J Endocrinol Invest"},{"key":"12749_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00508-y","author":"G Lamberti","year":"2024","unstructured":"Lamberti G et al (2024) Gastric neuroendocrine neoplasms. Nat Rev Dis Prim. https:\/\/doi.org\/10.1038\/s41572-024-00508-y","journal-title":"Nat Rev Dis Prim"},{"key":"12749_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04340-x","author":"S Uccella","year":"2025","unstructured":"Uccella S, La Rosa S (2025) Neuroendocrine neoplasms of the stomach. Update on diagnostic criteria, classification, and prognostic markers. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-025-04340-x","journal-title":"Virchows Arch"},{"key":"12749_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrc.2017.102","volume":"18","author":"K Curtius","year":"2018","unstructured":"Curtius K, Wright NA, Graham TA (2018) An evolutionary perspective on field cancerization. Nat Rev Cancer 18:19\u201332. https:\/\/doi.org\/10.1038\/nrc.2017.102","journal-title":"Nat Rev Cancer"},{"key":"12749_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-03079-6","author":"Y-Y Chen","year":"2023","unstructured":"Chen Y-Y et al (2023) Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study. BMC Gastroenterol. https:\/\/doi.org\/10.1186\/s12876-023-03079-6","journal-title":"BMC Gastroenterol"},{"key":"12749_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030828","author":"M Sheikh-Ahmad","year":"2023","unstructured":"Sheikh-Ahmad M et al (2023) Factors predicting type I gastric neuroendocrine neoplasia recurrence: a single-center study. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11030828","journal-title":"Biomedicines"},{"key":"12749_CR13","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1245\/s10434-021-10293-7","volume":"28","author":"A Hanna","year":"2021","unstructured":"Hanna A et al (2021) Gastric neuroendocrine tumors: reappraisal of type in predicting outcome. Ann Surg Oncol 28:8838\u20138846. https:\/\/doi.org\/10.1245\/s10434-021-10293-7","journal-title":"Ann Surg Oncol"},{"key":"12749_CR14","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1245\/s10434-021-10293-7","volume":"28","author":"A Hanna","year":"2021","unstructured":"Hanna A et al (2021) Gastric neuroendocrine tumors: reappraisal of type in predicting outcome. Ann Surg Oncol 28:8838\u20138846. https:\/\/doi.org\/10.1245\/s10434-021-10293-7","journal-title":"Ann Surg Oncol"},{"key":"12749_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/den.14529","volume":"35","author":"K Namikawa","year":"2023","unstructured":"Namikawa K et al (2023) Clinical characteristics and long-term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort. Dig Endosc 35:757\u2013766. https:\/\/doi.org\/10.1111\/den.14529","journal-title":"Dig Endosc"},{"key":"12749_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110544","volume":"51","author":"C Lv","year":"2025","unstructured":"Lv C et al (2025) Postoperative recurrence patterns and prognostic determinants in early-onset early-stage gastric cancer: a multicenter retrospective real-world study. Eur J Surg Oncol 51:110544. https:\/\/doi.org\/10.1016\/j.ejso.2025.110544","journal-title":"Eur J Surg Oncol"},{"key":"12749_CR17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-18613-x","author":"H Fei","year":"2025","unstructured":"Fei H et al (2025) Lymph node metastasis frequency and development of predictive model in T1b gastric cancer: a single-center study. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-025-18613-x","journal-title":"Ann Surg Oncol"},{"key":"12749_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1245\/s10434-025-18000-6","volume":"33","author":"S Chowdhury","year":"2026","unstructured":"Chowdhury S et al (2026) Recurrence after esophagectomy for esophageal cancer: high-volume center surveillance imaging outcomes. Ann Surg Oncol 33:467\u2013473. https:\/\/doi.org\/10.1245\/s10434-025-18000-6","journal-title":"Ann Surg Oncol"},{"key":"12749_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5009\/gnl240272","volume":"19","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Kim JY, Cho SJ, Kim SG, Chung H (2025) Clinical characteristics and long-term outcomes of gastric neuroendocrine tumors. Gut Liver 19:189\u2013197. https:\/\/doi.org\/10.5009\/gnl240272","journal-title":"Gut Liver"},{"key":"12749_CR20","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s11864-024-01207-2","volume":"25","author":"JW Kunstman","year":"2024","unstructured":"Kunstman JW, Nagar A, Gibson J, Kunz PL (2024) Modern management of gastric neuroendocrine neoplasms. Curr Treat Options Oncol 25:1137\u20131152. https:\/\/doi.org\/10.1007\/s11864-024-01207-2","journal-title":"Curr Treat Options Oncol"},{"key":"12749_CR21","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003235","author":"A Jove","year":"2024","unstructured":"Jove A et al (2024) Serum gastrin levels are associated with prevalent neuroendocrine tumors in autoimmune metaplastic atrophic gastritis. Am J Gastroenterol. https:\/\/doi.org\/10.14309\/ajg.0000000000003235","journal-title":"Am J Gastroenterol"},{"key":"12749_CR22","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000238","author":"R Magris","year":"2020","unstructured":"Magris R et al (2020) Low pepsinogen I\/II ratio and high gastrin-17 levels typify chronic atrophic autoimmune gastritis patients with gastric neuroendocrine tumors. Clin Transl Gastroenterol. https:\/\/doi.org\/10.14309\/ctg.0000000000000238","journal-title":"Clin Transl Gastroenterol"},{"key":"12749_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/cen.14055","volume":"91","author":"K Daskalakis","year":"2019","unstructured":"Daskalakis K et al (2019) Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms. Clin Endocrinol (Oxf) 91:534\u2013543. https:\/\/doi.org\/10.1111\/cen.14055","journal-title":"Clin Endocrinol (Oxf)"},{"key":"12749_CR24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.dld.2019.04.016","volume":"51","author":"F Panzuto","year":"2019","unstructured":"Panzuto F et al (2019) Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study. Dig Liver Dis 51:1456\u20131460. https:\/\/doi.org\/10.1016\/j.dld.2019.04.016","journal-title":"Dig Liver Dis"},{"key":"12749_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10620-023-08180-0","volume":"69","author":"XR Guo","year":"2024","unstructured":"Guo XR, Zhao XH, Huang G, Yu YB (2024) Advances in endoscopic diagnosis and treatment of gastric neuroendocrine neoplasms. Dig Dis Sci 69:27\u201335. https:\/\/doi.org\/10.1007\/s10620-023-08180-0","journal-title":"Dig Dis Sci"},{"key":"12749_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-024-00535-6","author":"X-B Zhang","year":"2024","unstructured":"Zhang X-B et al (2024) Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives. Mil Med Res. https:\/\/doi.org\/10.1186\/s40779-024-00535-6","journal-title":"Mil Med Res"},{"key":"12749_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/cm9.0000000000003029","volume":"137","author":"J Huang","year":"2024","unstructured":"Huang J et al (2024) Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: a multicenter retrospective study. Chin Med J 137:720\u2013728. https:\/\/doi.org\/10.1097\/cm9.0000000000003029","journal-title":"Chin Med J"},{"key":"12749_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12020-022-03143-3","volume":"78","author":"K Exarchou","year":"2022","unstructured":"Exarchou K et al (2022) Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter. Endocrine 78:186\u2013196. https:\/\/doi.org\/10.1007\/s12020-022-03143-3","journal-title":"Endocrine"},{"key":"12749_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.dld.2021.11.012","volume":"54","author":"G Esposito","year":"2022","unstructured":"Esposito G et al (2022) Management of type-I gastric neuroendocrine neoplasms: a 10-years prospective single centre study. Dig Liver Dis 54:890\u2013895. https:\/\/doi.org\/10.1016\/j.dld.2021.11.012","journal-title":"Dig Liver Dis"},{"key":"12749_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13440","author":"D Ravizza","year":"2024","unstructured":"Ravizza D et al (2024) Gastric neuroendocrine tumors: 20-year experience in a reference center. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.13440","journal-title":"J Neuroendocrinol"},{"key":"12749_CR31","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.dld.2019.04.016","volume":"51","author":"F Panzuto","year":"2019","unstructured":"Panzuto F et al (2019) Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study. Dig Liver Dis 51:1456\u20131460. https:\/\/doi.org\/10.1016\/j.dld.2019.04.016","journal-title":"Dig Liver Dis"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-12749-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:52:54Z","timestamp":1780926774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-12749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["12749"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-12749-x","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jingjin, Hejun Zhang, Shigang Ding, and Jing Zhang have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The Ethics Committee of Peking University Third Hospital approved this study (LM2025622).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}